Expertise in
19
conditions

Martin Gotthardt

Radboudumc
Nijmegen, GE, NL 
Expertise in
19
conditions
Radboudumc
Nijmegen, GE, NL 

Overview

Martin Gotthardt practices practicing medicine in Nijmegen, Netherlands.

Mr. Gotthardt is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Insulinoma, Salivary Gland Tumors, Adenoid Cystic Carcinoma, Islet Cell Transplantation, and Gastric Bypass.

He is actively involved in clinical research, co-authoring 175 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Radboudumc
Nijmegen, GE 6525GA, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Comparison of the Beta Cell Mass During and Shortly After the Honeymoon Phase of Type 1 Diabetes Using Gallium-68-exendin PET
Comparison of the Beta Cell Mass During and Shortly After the Honeymoon Phase of Type 1 Diabetes Using Gallium-68-exendin PET
Enrollment Status: Active_not_recruiting
Publish Date: January 05, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
Enrollment Status: Terminated
Publish Date: July 12, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Lutetium-177-PSMA Radioligand Therapy for Advanced Salivary Gland Cancer, a Phase II Pilot Study.
Lutetium-177-PSMA Radioligand Therapy for Advanced Salivary Gland Cancer, a Phase II Pilot Study.
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug
Study Drug: Lutetium-177-PSMA Radioligand
Study Phase: Phase 2
Adipose Tissue Imaging in Patients With Type 2 Diabetes, Pilot Study
Adipose Tissue Imaging in Patients With Type 2 Diabetes, Pilot Study
Enrollment Status: Completed
Publish Date: May 31, 2017
Intervention Type: Device, Radiation
Study Phase: Not Applicable
View 3 Less Clinical Trials

175 Total Publications

CXCR4-Targeted Molecular Imaging in Hematology and Oncology.
CXCR4-Targeted Molecular Imaging in Hematology and Oncology.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 22, 2026

Frequently Asked Questions about Martin Gotthardt

Is Martin Gotthardt a top-rated expert for Insulinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Martin Gotthardt is classified as an Elite expert for Insulinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin Gotthardt participate in research or clinical trials?

Yes. Martin Gotthardt has published 175 articles and abstracts on conditions like Insulinoma. You can view a list of Martin Gotthardt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gotthardt's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile